Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-07-10

FDA Approved: CYANOCOBALAMIN — Original Application (BluePoint Laboratories)

View source ↗

Summary

FDA approved Cyanocobalamin from BluePoint Laboratories via an Original Application. Indications include the treatment of Vitamin B12 deficiency, including pern…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYANOCOBALAMIN (cyanocobalamin)

Snippet

ORIG AP for CYANOCOBALAMIN (CYANOCOBALAMIN)